MOTIONAL AND COGNITIVE DISORDERS IN PATIENTS WITH ACUTE RESPIRATORY VIRAL INFECTIONS AND THE POSSIBILITY OF THEIR PHARMACOCORRECTION
DOI:
https://doi.org/10.32782/health-2024.1.24Keywords:
emotional and cognitive disorders, acute respiratory viral infections, probiotic, Probeez® ImmunoAbstract
It is known that respiratory viral infections not only negatively affect the functional state of the immune system, gastrointestinal tract, but also induce a cluster of emotional-cognitive disorders, causing emotional lability, anxiety and disturbances in sleep, memory, attention deficit and cognitive impairment. Cognitive impairments, which are registered against the background and after a viral disease, have a negative effect on the central nervous system similar to the toxic effect of alcohol and are manifested by a decrease in cognitive performance and emotional lability. In clinical studies, it has been proven that 90% of patients who have contracted an acute respiratory viral infection have post-infectious asthenia symptoms, decreased concentration of attention, lethargy of thinking, etc. Unfortunately, the latest violations are usually ignored by the medical community. The purpose of this work was to study the effect of the probiotic-vitamin complex with plant extracts of Probeez® Immuno on certain indicators of the emotional and cognitive sphere in patients with acute respiratory viral infections (ARVI). The study involved 38 patients with acute respiratory viral infection, influenza, COVID-19, as well as 10 healthy volunteers. The psychological study included the methods of "proofreading test", the study of self-esteem according to the Dembo-Rubinstein method in the modification of Prikhozhan A.M. It was found that the ten-day use of the Probeez® Immuno complex, which contains spores of Bacillus coagulans Unique IS-2 (2.00×109 CFU); Spinach (126 mg); Vitamin C (40 mg); Aloe Vera (43 mg); Basil (29 mg); wheat germ (29 mg); Chlorella (19 mg); Lemongrass (19 mg); Mint (15 mg); Moringa (15 mg); Zinc (10 mg); Spirulina (9 mg); Vitamin E (7.5 mg); Vitamin B5 (5 mg); Vitamin B6 (2 mg); Vitamin A (600 μg); Vitamin D3 (10 μg); Vitamin B12 (1.0 μg) contributed to the normalization of the indicators of the emotional and cognitive sphere of patients. Probeez® Immuno not only helps to improve digestion, but probably reduces the manifestations of astheno-vegetative syndrome.
References
Smith B. Colds and cognition. Monitor on Psychology. 2013. № 44 (2). Р. 34–46.
Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021. № 52(6). P. 575–581.
Smith B.W., Kay V.S., Hoyt T.V., Bernard M.L. Predicting the anticipated emotional and behavioral responses to an avian flu outbreak. Am J Infect Control. 2009. № 37(5). P. 371–380.
Busch I.M., Moretti F., Mazzi M., Wu A.W., Rimondini M. What We Have Learned from Two Decades of Epidemics and Pandemics: A Systematic Review and Meta-Analysis of the Psychological Burden of Frontline Healthcare Workers. Psychother Psychosom. 2021. № 90(3). P. 178–190.
Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O'Hara M., Suett J., Dahmash D., Bugaeva P., Rigby I., Munblit D., Harriss E., Burls A., Foote C., Scott J., Carson G., Olliaro P., Sigfrid L., Stavropoulou C. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021. № 6(9). Art. e005427.
Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol. 2021. № 20. P. 1–9.
Wijeratne T., Gillard Crewther S., Sales C., Karimi L. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review. Front Neurol. 2021. № 11. Art. 607221.
Silva Andrade B., Siqueira S., de Assis Soares W.R. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021. № 13(4). Art. 700.
Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021. № 36. Art. 100899.
Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne). 2021. № 8. Art. 653516.
Wischmeyer P.E., Tang H., Ren Y., Bohannon L. Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial. Clin Nutr. 2024. № 43(1). P. 259–267.
Sher L. Post-COVID syndrome and suicide risk. QJM. 2021. № 114(2). P. 95–98.
Lamprecht B. Gibt es ein Post-COVID-Syndrom? [Is there a post-COVID syndrome?]. Pneumologe (Berl). 2020. № 17(6). P. 398–405.
Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021. № 52(6). P. 575–581.
Maltezou H.C., Pavli A., Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021. № 9(5). Art. 497.
Camargo-Martínez W., Lozada-Martínez I., Escobar-Collazos A., Navarro-Coronado A. Post-COVID 19 neurological syndrome: Implications for sequelae's treatment. J Clin Neurosci. 2021. № 88. P. 219–225.
Capuco A., Urits I., Hasoon J., Chun R., Gerald B., Wang J.K., Kassem H., Ngo A.L., Abd-Elsayed A., Simopoulos T., Kaye A.D., Viswanath O. Current Perspectives on Gut Microbiome Dysbiosis and Depression. Adv Ther. 2020. № 37(4). P. 1328–1346.
Tsubanova N.A., Chernyavsky E.S. Clinical and Pharmacological Portrait of the Innovative Combined Agent «Probiz Immuno». Mystektvo likuvannya. 2020. № 9(175). P. 71–77.
Sampath S., Mahapatra S.C., Padhi M.M., Sharma R., Talwar A. Holy basil (Ocimum sanctum Linn.) leaf extract enhances specific cognitive parameters in healthy adult volunteers: A placebo controlled study. Indian J Physiol Pharmacol. 2015. № 59(1). P. 69–77.
Kennedy D., Okello E., Chazot P., Howes M.J., Ohiomokhare S. Volatile Terpenes and Brain Function: Investigation of the Cognitive and Mood Effects of Mentha Piperita L. Essential Oil with In Vitro Properties Relevant to Central Nervous System Function. Nutrients. 2018. № 10(8). Art. 1029.
Chumpitazi B.P., Kearns G.L., Shulman R.J. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018. № 47(6). P. 738–752.
Zeng J., Hu W., Li H., Liu J., Zhang P., Gu Y., Yu Y., Wang W., Wei Y. Purification of linarin and hesperidin from Mentha haplocalyx by aqueous two-phase flotation coupled with preparative HPLC and evaluation of the neuroprotective effect of linarin. J Sep Sci. 2021. № 44(12). P. 2496–2503.
Hacke A.C., Miyoshi E., Marques J.A., Pereira R.P. Cymbopogon citratus (DC.) Stapf, citral and geraniol exhibit anticonvulsant and neuroprotective effects in pentylenetetrazole-induced seizures in zebrafish. J Ethnopharmacol. 2021. № 275. Art. 114142.
Santos P.L., Matos J.P.S.C.F., Picot L., Almeida J.R.G.S., Quintans J.S.S., Quintans-Júnior L.J. Citronellol, a monoterpene alcohol with promising pharmacological activities – A systematic review. Food Chem Toxicol. 2019. № 123. P. 459–469.
